メディパル HD（7459）のセグメントごとの売上高・利益等
セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
|---|---|---|---|---|
| 売上高 | 2013/03 | 2.01兆 | 0.76兆 | - |
| 2014/03 | 2.1兆 +4.5% | 0.8兆 +5.8% | - | |
| 2015/03 | 2.04兆 -3.1% | 0.79兆 -1.3% | - | |
| 2016/03 | 2.12兆 +4.2% | 0.86兆 +8.3% | - | |
| 2017/03 | 2.08兆 -1.8% | 0.92兆 +7.2% | - | |
| 2018/03 | 2.12兆 +1.6% | 0.97兆 +4.9% | - | |
| 2019/03 | 2.1兆 -0.8% | 1.01兆 +5% | - | |
| 2020/03 | 2.14兆 +1.8% | 1.05兆 +3.1% | - | |
| 2021/03 | 2.11兆 -1.4% | 1.03兆 -1.2% | - | |
| 2022/03 | 2.17兆 +3.1% | 1.05兆 +1.2% | 719億 | |
| 2023/03 | 2.18兆 +0.4% | 1.1兆 +5.6% | 740億 +2.9% | |
| 2024/03 | 2.29兆 +5.1% | 1.15兆 +4.3% | 1140億 +54.2% | |
| 2025/03 | 2.37兆 +3.2% | 1.19兆 +3.1% | 1169億 +2.5% | |
| 2026/03 | 2.46兆 +4% | 1.24兆 +4.2% | 1173億 +0.4% | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| 営業利益 | 2013/03 | 146億 | 129億 | - |
| 2014/03 | 196億 +33.9% | 140億 +8.1% | - | |
| 2015/03 | 176億 -10.3% | 142億 +1.2% | - | |
| 2016/03 | 245億 +39.7% | 163億 +15% | - | |
| 2017/03 | 187億 -23.9% | 191億 +17.4% | - | |
| 2018/03 | 194億 +4.1% | 230億 +20.2% | - | |
| 2019/03 | 225億 +15.6% | 254億 +10.4% | - | |
| 2020/03 | 261億 +16% | 247億 -2.7% | - | |
| 2021/03 | 105億 -59.6% | 255億 +3.2% | - | |
| 2022/03 | 166億 +57.9% | 259億 +1.8% | 26.9億 | |
| 2023/03 | 219億 +31.9% | 245億 -5.6% | 25.3億 -6% | |
| 2024/03 | 175億 -20.3% | 272億 +11% | 27.3億 +8% | |
| 2025/03 | 252億 +44.3% | 280億 +3.1% | 24.4億 -10.4% | |
| 2026/03 | 243億 -3.6% | 264億 -5.6% | 23.3億 -4.9% | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| 営業利益率 | 2013/03 | 0.7% | 1.7% | - |
| 2014/03 | 0.9% +0.2% | 1.7% ±0% | - | |
| 2015/03 | 0.9% ±0% | 1.8% +0.1% | - | |
| 2016/03 | 1.2% +0.3% | 1.9% +0.1% | - | |
| 2017/03 | 0.9% -0.3% | 2.1% +0.2% | - | |
| 2018/03 | 0.9% ±0% | 2.4% +0.3% | - | |
| 2019/03 | 1.1% +0.2% | 2.5% +0.1% | - | |
| 2020/03 | 1.2% +0.1% | 2.4% -0.1% | - | |
| 2021/03 | 0.5% -0.7% | 2.5% +0.1% | - | |
| 2022/03 | 0.8% +0.3% | 2.5% ±0% | 3.7% | |
| 2023/03 | 1% +0.2% | 2.2% -0.3% | 3.4% -0.3% | |
| 2024/03 | 0.8% -0.2% | 2.4% +0.2% | 2.4% -1% | |
| 2025/03 | 1.1% +0.3% | 2.4% ±0% | 2.1% -0.3% | |
| 2026/03 | 1% -0.1% | 2.1% -0.3% | 2% -0.1% | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| 研究開発費 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | - | - | - | |
| 2018/03 | - | - | - | |
| 2019/03 | - | - | - | |
| 2020/03 | - | - | - | |
| 2021/03 | - | - | - | |
| 2022/03 | - | - | - | |
| 2023/03 | - | - | - | |
| 2024/03 | 225百万 | 88百万 | 677百万 | |
| 2025/03 | 599百万 +166.2% | 69百万 -21.6% | 750百万 +10.8% | |
| 2026/03 | 683百万 +14% | 21百万 -69.6% | 808百万 +7.7% | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| 固定資産増加額 | 2013/03 | 106億 | 108億 | - |
| 2014/03 | 126億 +19.6% | 122億 +12.5% | - | |
| 2015/03 | 146億 +15.6% | 7.48億 -93.9% | - | |
| 2016/03 | 240億 +64.3% | 158億 +999.99% | - | |
| 2017/03 | 350億 +45.6% | 97.9億 -37.9% | - | |
| 2018/03 | 69億 -80.3% | 136億 +39.4% | - | |
| 2019/03 | 84億 +21.7% | 107億 -21.6% | - | |
| 2020/03 | 103億 +23% | 188億 +75.6% | - | |
| 2021/03 | 107億 +3.5% | 53.5億 -71.5% | - | |
| 2022/03 | 81.5億 -23.8% | 97.3億 +81.7% | 267百万 | |
| 2023/03 | 64.1億 -21.4% | 102億 +5% | 121百万 -54.7% | |
| 2024/03 | 182億 +183.9% | 15.6億 -84.7% | 472百万 +290.1% | |
| 2025/03 | 115億 -36.5% | 18.1億 +16.1% | 702百万 +48.7% | |
| 2026/03 | 67.1億 -41.9% | 26.6億 +46.7% | 486百万 -30.8% | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| 従業員数 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | - | - | - | |
| 2018/03 | - | - | - | |
| 2019/03 | 10,923 | 2,207 | - | |
| 2020/03 | 10,691 -2.1% | 2,196 -0.5% | - | |
| 2021/03 | 10,088 -5.6% | 2,169 -1.2% | - | |
| 2022/03 | 9,916 -1.7% | 2,168 ±-0% | - | |
| 2023/03 | 9,682 -2.4% | 2,187 +0.9% | 742 | |
| 2024/03 | 9,900 +2.3% | 2,237 +2.3% | 745 +0.4% | |
| 2025/03 | 9,836 -0.6% | 2,283 +2.1% | 746 +0.1% | |
| 2026/03 | 9,667 -1.7% | 2,363 +3.5% | 796 +6.7% | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| 平均臨時雇用人員 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | - | - | - | |
| 2018/03 | - | - | - | |
| 2019/03 | 2,647 | 5,096 | - | |
| 2020/03 | 2,621 -1% | 5,051 -0.9% | - | |
| 2021/03 | 2,742 +4.6% | 4,749 -6% | - | |
| 2022/03 | 2,764 +0.8% | 4,794 +0.9% | - | |
| 2023/03 | 3,259 +17.9% | 5,046 +5.3% | 112 | |
| 2024/03 | 4,591 +40.9% | 5,356 +6.1% | 115 +2.7% | |
| 2025/03 | 5,109 +11.3% | 5,574 +4.1% | 121 +5.2% | |
| 2026/03 | 5,107 ±-0% | 5,856 +5.1% | 97 -19.8% | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| 資産 | 2013/03 | 0.95兆 | 2944億 | - |
| 2014/03 | 0.99兆 +4.1% | 3163億 +7.4% | - | |
| 2015/03 | 0.99兆 -0.5% | 3100億 -2% | - | |
| 2016/03 | 0.99兆 +0.1% | 3443億 +11% | - | |
| 2017/03 | 1.12兆 +13.3% | 3541億 +2.9% | - | |
| 2018/03 | 1.17兆 +4.5% | 3807億 +7.5% | - | |
| 2019/03 | 1.17兆 -0.2% | 3870億 +1.7% | - | |
| 2020/03 | 1.14兆 -1.9% | 4138億 +6.9% | - | |
| 2021/03 | 1.14兆 +0.1% | 4315億 +4.3% | - | |
| 2022/03 | 1.16兆 +1.2% | 4449億 +3.1% | 280億 | |
| 2023/03 | 1.13兆 -2.2% | 4729億 +6.3% | 872億 +211.6% | |
| 2024/03 | 1.19兆 +5.5% | 4925億 +4.1% | 873億 +0.1% | |
| 2025/03 | 1.2兆 +0.4% | 5036億 +2.3% | 830億 -5% | |
| 2026/03 | 1.26兆 +5% | 5292億 +5.1% | 803億 -3.2% | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| 減損損失 | 2013/03 | 8.92億 | 81百万 | - |
| 2014/03 | 4.15億 -53.5% | 288百万 +255.6% | - | |
| 2015/03 | 2.19億 -47.2% | 79百万 -72.6% | - | |
| 2016/03 | 9.17億 +318.7% | 362百万 +358.2% | - | |
| 2017/03 | 9.52億 +3.8% | 108百万 -70.2% | - | |
| 2018/03 | 2.41億 -74.7% | 83百万 -23.1% | - | |
| 2019/03 | 0.07億 -97.1% | - | - | |
| 2020/03 | 8.55億 +999.99% | 18百万 | - | |
| 2021/03 | 15.8億 +84.8% | - | - | |
| 2022/03 | 1億 -93.7% | - | - | |
| 2023/03 | 2.64億 +164% | - | 1百万 | |
| 2024/03 | 0.67億 -74.6% | 639百万 | - | |
| 2025/03 | 2.46億 +267.2% | - | 32百万 | |
| 2026/03 | 5.65億 +129.7% | 104百万 | - | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| 持分法適用会社への投資額 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | 241億 | - | - | |
| 2018/03 | 474億 +96.9% | - | - | |
| 2019/03 | 528億 +11.3% | - | - | |
| 2020/03 | 539億 +2.1% | - | - | |
| 2021/03 | 569億 +5.6% | - | - | |
| 2022/03 | 602億 +5.7% | - | - | |
| 2023/03 | 599億 -0.4% | - | - | |
| 2024/03 | 626億 +4.5% | - | - | |
| 2025/03 | 582億 -7.1% | - | - | |
| 2026/03 | 606億 +4% | - | - | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| のれん | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | 620百万 | - | |
| 2017/03 | - | 482百万 -22.3% | - | |
| 2018/03 | 16.3億 | 344百万 -28.6% | - | |
| 2019/03 | 13.7億 -15.7% | 206百万 -40.1% | - | |
| 2020/03 | 11.2億 -18.6% | 68百万 -67% | - | |
| 2021/03 | 8.6億 -22.9% | - | - | |
| 2022/03 | 6.04億 -29.8% | - | - | |
| 2023/03 | 3.49億 -42.2% | - | 116億 | |
| 2024/03 | 4.91億 +40.7% | - | 111億 -3.6% | |
| 2025/03 | 28.1億 +472.5% | - | 103億 -7.1% | |
| 2026/03 | 24億 -14.8% | - | 99.5億 -3.8% | |
| 科目 | 年度 | 医療用医薬品等卸売事業 | 化粧品・日用品、一般用医薬品卸売事業 | 動物用医薬品・食品加工原材料卸売等関連事業 |
| のれん償却額 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | 68百万 | - | |
| 2017/03 | - | 137百万 +101.5% | - | |
| 2018/03 | 255百万 | 137百万 ±0% | - | |
| 2019/03 | 255百万 ±0% | 137百万 ±0% | - | |
| 2020/03 | 255百万 ±0% | 137百万 ±0% | - | |
| 2021/03 | 255百万 ±0% | 68百万 -50.4% | - | |
| 2022/03 | 255百万 ±0% | - | - | |
| 2023/03 | 255百万 ±0% | - | - | |
| 2024/03 | 254百万 -0.4% | - | 7.97億 | |
| 2025/03 | 506百万 +99.2% | - | 7.95億 -0.3% | |
| 2026/03 | 415百万 -18% | - | 103億 +999.99% |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 医療用医薬品等卸売事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 0.51兆 | 0.51兆 | 0.56兆 | 0.52兆 | 2.1兆 |
| 2015/03 | 0.49兆 -4.5% | 0.49兆 -2.5% | 0.55兆 -1.7% | 0.5兆 -3.6% | 2.04兆 -3.1% | |
| 2016/03 | 0.52兆 +6.7% | 0.52兆 +4.5% | 0.57兆 +3.5% | 0.52兆 +2.3% | 2.12兆 +4.2% | |
| 2017/03 | 0.52兆 +0.3% | 0.5兆 -2.4% | 0.55兆 -3% | 0.51兆 -2% | 2.08兆 -1.8% | |
| 2018/03 | 0.52兆 -0.1% | 0.51兆 +1.7% | 0.57兆 +3.5% | 0.51兆 +1.3% | 2.12兆 +1.6% | |
| 2019/03 | 0.53兆 +0.9% | 0.5兆 -1.9% | 0.56兆 -1.1% | 0.51兆 -0.9% | 2.1兆 -0.8% | |
| 2020/03 | 0.53兆 +0.9% | 0.54兆 +8.2% | 0.56兆 -1% | 0.51兆 -0.5% | 2.14兆 +1.8% | |
| 2021/03 | 0.52兆 -2.7% | 0.51兆 -5.9% | 0.56兆 +1.2% | 0.52兆 +1.9% | 2.11兆 -1.4% | |
| 2022/03 | 0.54兆 +3.9% | 0.54兆 +5.3% | 0.57兆 +1.7% | 0.52兆 +1.5% | 2.17兆 +3.1% | |
| 2023/03 | 0.54兆 +1.2% | 0.55兆 +2.1% | 0.57兆 -0.9% | 0.52兆 -0.8% | 2.18兆 +0.4% | |
| 2024/03 | 0.56兆 +3.8% | 0.57兆 +4.4% | 0.61兆 +6.5% | 0.55兆 +5.5% | 2.29兆 +5.1% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 33.9億 | 45.6億 | 63億 | 53.2億 | 196億 |
| 2015/03 | 38.4億 +13.2% | 29.5億 -35.3% | 51億 -19% | 56.7億 +6.6% | 176億 -10.3% | |
| 2016/03 | 36.7億 -4.4% | 53.4億 +81.2% | 87.1億 +70.9% | 68.1億 +20.1% | 245億 +39.7% | |
| 2017/03 | 64億 +74.5% | 27.4億 -48.7% | 63.4億 -27.2% | 31.9億 -53.2% | 187億 -23.9% | |
| 2018/03 | 23.1億 -64% | 39.8億 +45.3% | 75.3億 +18.7% | 56.2億 +76.4% | 194億 +4.1% | |
| 2019/03 | 41.2億 +78.4% | 42億 +5.5% | 99.2億 +31.7% | 42.4億 -24.7% | 225億 +15.6% | |
| 2020/03 | 52.4億 +27.3% | 75.4億 +79.7% | 86.7億 -12.6% | 46.1億 +8.8% | 261億 +16% | |
| 2021/03 | 36.6億 -30.1% | -1.14億 赤字 | 37.6億 -56.7% | 32.2億 -30.2% | 105億 -59.6% | |
| 2022/03 | 53.7億 +46.7% | 39.1億 | 49.3億 +31.3% | 24億 -25.5% | 166億 +57.9% | |
| 2023/03 | 62.1億 +15.6% | 58.1億 +48.3% | 42億 -14.8% | 57億 +137.8% | 219億 +31.9% | |
| 2024/03 | 46.5億 -25.2% | 7.17億 -87.7% | 76.5億 +82% | 44.6億 -21.7% | 175億 -20.3% | |
| 営業利益率 | 2014/03 | 0.7% | 0.9% | 1.1% | 1% | 0.9% |
| 2015/03 | 0.8% +0.1% | 0.6% -0.3% | 0.9% -0.2% | 1.1% +0.1% | 0.9% ±0% | |
| 2016/03 | 0.7% -0.1% | 1% +0.4% | 1.5% +0.6% | 1.3% +0.2% | 1.2% +0.3% | |
| 2017/03 | 1.2% +0.5% | 0.5% -0.5% | 1.2% -0.3% | 0.6% -0.7% | 0.9% -0.3% | |
| 2018/03 | 0.4% -0.8% | 0.8% +0.3% | 1.3% +0.1% | 1.1% +0.5% | 0.9% ±0% | |
| 2019/03 | 0.8% +0.4% | 0.8% ±0% | 1.8% +0.5% | 0.8% -0.3% | 1.1% +0.2% | |
| 2020/03 | 1% +0.2% | 1.4% +0.6% | 1.6% -0.2% | 0.9% +0.1% | 1.2% +0.1% | |
| 2021/03 | 0.7% -0.3% | -0% | 0.7% -0.9% | 0.6% -0.3% | 0.5% -0.7% | |
| 2022/03 | 1% +0.3% | 0.7% | 0.9% +0.2% | 0.5% -0.1% | 0.8% +0.3% | |
| 2023/03 | 1.1% +0.1% | 1.1% +0.4% | 0.7% -0.2% | 1.1% +0.6% | 1% +0.2% | |
| 2024/03 | 0.8% -0.3% | 0.1% -1% | 1.3% +0.6% | 0.8% -0.3% | 0.8% -0.2% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 化粧品・日用品、一般用医薬品卸売事業 | ||||||
| 売上高 1Q2Q | 2014/03 | 0.2兆 | 0.21兆 | 0.2兆 | 0.2兆 | 0.8兆 |
| 2015/03 | 0.19兆 -2% | 0.21兆 +0.6% | 0.2兆 +1.1% | 0.19兆 -5.2% | 0.79兆 -1.3% | |
| 2016/03 | 0.21兆 +8.4% | 0.22兆 +3.8% | 0.23兆 +10.6% | 0.21兆 +10.8% | 0.86兆 +8.3% | |
| 2017/03 | 0.23兆 +11.8% | 0.24兆 +11.5% | 0.23兆 +2.9% | 0.21兆 +2.6% | 0.92兆 +7.2% | |
| 2018/03 | 0.24兆 +3.5% | 0.25兆 +4.9% | 0.24兆 +4.4% | 0.23兆 +6.9% | 0.97兆 +4.9% | |
| 2019/03 | 0.26兆 +7.3% | 0.26兆 +3.7% | 0.26兆 +5.9% | 0.24兆 +3.2% | 1.01兆 +5% | |
| 2020/03 | 0.26兆 +0.8% | 0.28兆 +8.1% | 0.25兆 -1.7% | 0.25兆 +5.3% | 1.05兆 +3.1% | |
| 2021/03 | 0.26兆 -1% | 0.27兆 -6% | 0.27兆 +5.3% | 0.24兆 -2.9% | 1.03兆 -1.2% | |
| 2022/03 | 0.27兆 +3.7% | 0.26兆 -1.4% | 0.27兆 +1.4% | 0.24兆 +1.2% | 1.05兆 +1.2% | |
| 2023/03 | 0.28兆 +2.4% | 0.28兆 +6.4% | 0.29兆 +8.4% | 0.26兆 +5.1% | 1.1兆 +5.6% | |
| 2024/03 | 0.29兆 +6.3% | 0.29兆 +4% | 0.3兆 +2.2% | 0.27兆 +5.1% | 1.15兆 +4.3% | |
| 営業利益 1Q2Q | 2014/03 | 31.8億 | 41.9億 | 34.2億 | 32億 | 140億 |
| 2015/03 | 28.3億 -11% | 43.6億 +3.9% | 38.6億 +12.8% | 31.1億 -2.7% | 142億 +1.2% | |
| 2016/03 | 40.1億 +41.8% | 46.2億 +6% | 42.5億 +10.2% | 34億 +9.4% | 163億 +15% | |
| 2017/03 | 47.2億 +17.8% | 59.7億 +29.3% | 51.7億 +21.5% | 32.5億 -4.4% | 191億 +17.4% | |
| 2018/03 | 58.8億 +24.4% | 65.6億 +9.9% | 63.7億 +23.2% | 41.7億 +28.3% | 230億 +20.2% | |
| 2019/03 | 69.1億 +17.5% | 68.3億 +4.1% | 67.3億 +5.7% | 49.1億 +17.6% | 254億 +10.4% | |
| 2020/03 | 62.5億 -9.5% | 75.3億 +10.2% | 56.1億 -16.6% | 52.9億 +7.8% | 247億 -2.7% | |
| 2021/03 | 60.8億 -2.7% | 69.5億 -7.7% | 69億 +23% | 55.4億 +4.7% | 255億 +3.2% | |
| 2022/03 | 70.1億 +15.2% | 63.4億 -8.8% | 68.9億 -0.1% | 56.9億 +2.6% | 259億 +1.8% | |
| 2023/03 | 65.1億 -7% | 54.5億 -14.1% | 71.5億 +3.8% | 53.6億 -5.7% | 245億 -5.6% | |
| 2024/03 | 69.7億 +7% | 68億 +24.8% | 82億 +14.7% | 52億 -2.9% | 272億 +11% | |
| 営業利益率 | 2014/03 | 1.6% | 2% | 1.7% | 1.6% | 1.7% |
| 2015/03 | 1.5% -0.1% | 2.1% +0.1% | 1.9% +0.2% | 1.7% +0.1% | 1.8% +0.1% | |
| 2016/03 | 1.9% +0.4% | 2.1% ±0% | 1.9% ±0% | 1.6% -0.1% | 1.9% +0.1% | |
| 2017/03 | 2% +0.1% | 2.5% +0.4% | 2.2% +0.3% | 1.5% -0.1% | 2.1% +0.2% | |
| 2018/03 | 2.4% +0.4% | 2.6% +0.1% | 2.6% +0.4% | 1.8% +0.3% | 2.4% +0.3% | |
| 2019/03 | 2.7% +0.3% | 2.6% ±0% | 2.6% ±0% | 2.1% +0.3% | 2.5% +0.1% | |
| 2020/03 | 2.4% -0.3% | 2.7% +0.1% | 2.2% -0.4% | 2.1% ±0% | 2.4% -0.1% | |
| 2021/03 | 2.3% -0.1% | 2.6% -0.1% | 2.6% +0.4% | 2.3% +0.2% | 2.5% +0.1% | |
| 2022/03 | 2.6% +0.3% | 2.4% -0.2% | 2.5% -0.1% | 2.3% ±0% | 2.5% ±0% | |
| 2023/03 | 2.4% -0.2% | 2% -0.4% | 2.4% -0.1% | 2.1% -0.2% | 2.2% -0.3% | |
| 2024/03 | 2.4% ±0% | 2.3% +0.3% | 2.7% +0.3% | 1.9% -0.2% | 2.4% +0.2% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 動物用医薬品・食品加工原材料卸売等関連事業 | ||||||
| 売上高 1Q2Q 3Q | 2023/03 | 185億 | 182億 | 195億 | 177億 | 740億 |
| 2024/03 | 289億 +55.7% | 279億 +53% | 299億 +53.7% | 273億 +54.3% | 1140億 +54.2% | |
| 営業利益 1Q2Q 3Q | 2023/03 | 6.92億 | 6.83億 | 7.82億 | 3.68億 | 25.3億 |
| 2024/03 | 8.31億 +20.1% | 7.06億 +3.4% | 7.3億 -6.6% | 4.6億 +25% | 27.3億 +8% | |
| 営業利益率 | 2023/03 | 3.7% | 3.7% | 4% | 2.1% | 3.4% |
| 2024/03 | 2.9% -0.8% | 2.5% -1.2% | 2.4% -1.6% | 1.7% -0.4% | 2.4% -1% | |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
